-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
In view of the fact that HIV- infected persons cause high blood pressure to occur in a unique way.
Infected medsci.
Among veterans with HIV infection and high blood pressure (2000-2018), researchers used propensity score matching to assess (1) incident/recurrent CVD or death, and (2) incident CVD according to the type of antihypertensive drug And (3) the risk of event heart failure.
Among 8041 veterans, 24% started taking ACE (Angiotensin Converting Enzyme) inhibitor/ARB (Angiotensin Receptor Blocker) monotherapy, and 23% of patients received thiazides/thiazides Diuretic monotherapy, 13% of patients received beta-blocker monotherapy, and 11% of patients received calcium channel blocker monotherapy.
Compared with ACEIs/ARB, β-blockers, rather than calcium channel blockers or diuretics, are associated with an increased risk of CVD (hazard ratio [95% CI], for β-blockers it is 1.
In summary, researchers have observed a high incidence of CVD in HIV-infected patients with hypertension, and the use of beta-blockers for initial hypertension treatment is high, even in patients without indications .
Researchers have observed a high incidence of CVD in HIV-infected patients with high blood pressure, and the use of beta-blockers for initial hypertension treatment is high, even in patients without indications.
Original source:
Leah B.
